What's next

Marinko, Pam; Woodruff, Steve
June 2007
Pharmaceutical Representative;Jun2007, Vol. 37 Issue 6, p30
The article reports on the changes in the healthcare industry, which endangers the role of pharmaceutical sales representatives in the U.S. The demands from external forces decreased access and actual face-to-face time with physicians as the number of representatives increased. However, there will always be a need for well-qualified pharmaceutical representatives to engage physicians in the frontline of care despite market pressures.


Related Articles

  • CVS redefines pharmacy care for the future. Eder, Rob // Drug Store News;10/9/2006, Vol. 28 Issue 13, p51 

    The article focuses on the transformational events and defining initiatives by CVS Corp. on the larger claim to the future of health care and pharmacy care. CVS is on the run to finish this 2006 with more than 6,200 stores and total sales of almost $44 billion. The company's future has begun...

  • QUOTABLES.  // Pharmaceutical Executive;Mar2006, Vol. 26 Issue 3, p34 

    The article presents quotations regarding medical and pharmaceutical services in the U.S.

  • Centre of attraction. van Liedekerke, Beatrij // Pharmaceutical Technology Europe;Jan2008, Vol. 20 Issue 1, p38 

    The pharmaceutical industry in Asia is gearing up to be at the centre of the global market. Most pharmaceutical companies in the region expect this shift to happen fast. Not only is Asia set to become the largest pharmaceutical market in the world, but many Asian territories will be the...

  • Drugstore owners fight change. Alvarado, Angeles // Caribbean Business;9/14/1995, Vol. 23 Issue 37, p6 

    Reports on the opposition of pharmacy owners in Puerto Rico against a proposal by certain health plans and health care associations to restrict the number of pharmacies where plan subscribers can purchase their medicines. Effects of the proposal on the quality of medical care and the patients'...

  • ScriptPro rated top pharmacy automation. Ukens, Carol // Drug Topics;1/10/2005, Vol. 149 Issue 1, p50 

    Reports on business-related developments for the pharmaceutical industry in the U.S. Rating of ScriptPro as the winner in 23 categories; Agreement signed between Parata Systems and Kerr Group; Expansion of the screen and work areas of Cardinal Health.

  • Company Overview.  // AstraZeneca, PLC SWOT Analysis;Sep2007, p4 

    An overview of pharmaceutical company AstraZeneca PLC is presented. Data is included on revenues generated in the fiscal year ended December 2006, as well as principal business offered, including discovery, development, manufacture and marketing of prescription pharmaceuticals for healthcare.

  • Key Facts.  // AstraZeneca, PLC SWOT Analysis;Sep2007, p4 

    Key facts about pharmaceutical company AstraZeneca PLC are presented. Address and contact information is given, as well as statistics on revenues, financial year end data and number of employees. Information on market ticker is also supplied.

  • Adaptability is the key to success. Boswell, Clay // ICIS Chemical Business;2/15/2010, Vol. 277 Issue 6, p5 

    The article presents the author's views on the prospects of company that supplies the pharmaceutical industry. The author states that these are difficult times for any company that supplies the pharmaceutical industry. According to the author, in the longer term, companies that can most readily...

  • Growth medium. Mirasol, Feliza // ICIS Chemical Business;10/12/2009, Vol. 276 Issue 13, p28 

    The article reports on the growth of contract biologies manufacturers with the growing demand from pharmaceutical companies. The increase in demand for biotechnology drugs continues to drive the industry for contract manufacturing services, says William Downey, president of HighTech Business...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics